All Type of News
Price cuts corner local drugmakers
With multinationals taking up three-quarters of the local drug market, Korean makers will be unable to develop their own drugs if the government’s pressure to reduce medication costs continues, according to market ins...
KFDA announces aid package for local vaccine production
The Korea Food and Drug Administration says it has launched a task force consisting of 18 experts from the government and industry to help produce a variety of homegrown vaccines to prevent Hib, tuberculosis and hepat...
Dulcolax marketing lures Korean drug makers
Boehringer Ingelheim Korea is seeking a promising Korean partner to market its leading product Dulcolax, which has been distributed by Zuellig Pharma Korea.
Boehringer is said to select one Korean company as its pa...
AstraZeneca to conduct Phase II study for olaparib
The battle against cancer seems to be on the verge of a major step forward. The success of a new class of drugs “PARP inhibitors” in destroying the disease points to a new direction in the development of anticancer dr...
Latin America, emerging markets for Korean drug manufacturers
Intensifying generic competition and regulatory developments in Latin America are making these markets more attractive for Korean pharmaceutical companies, according to a local report.
Korea Trade Investment Promot...
Medical industry seeks medication costs saving
Korean doctors are launching a campaign to save medication costs by reducing the number of prescribing drugs or prescribing low-priced medicines, according to the Korean Medical Association.
KMA has launched a drug...
Wholesalers, Zuellig at odds over new contract
A dispute is brewing between domestic wholesalers and Zuellig Pharma Korea (ZPK), after ZPK delivered a letter dated February 9 to the Korea Association of Pharmaceutical Wholesaler to stop the undue intervention over...
KFDA to launch database for small package system
The Korea Food and Drug Administration says that the small package system should be backed by a new database that may keep tract of necessary drugs in small package.
The drug agency is now striving to overhaul the ...
Drug price poses dilemma
The government’s plan to evaluate the economic effectiveness of existing insurance-covered medicines has posed a new dilemma for those who are involved in drug prices in pharmaceutical firms.
“The government’s pre...
Green Cross US FDA OK to test new anti-Parkinsonian drug candidate
Green Cross Corporation said on February 10 it has received approval from the U.S. Food and Drug Administration to start an early-stage human trial of GCC1290K for the treatment of Parkinson’s disease.
The company ...
